Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : NVO    save search

Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-17 (Crawled : 23:00) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology


Novo Nordisk Brokers Another Deal in Fight Against Obesity
Published: 2022-01-17 (Crawled : 16:00) - biospace.com/
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology

obesity deal
Novo Nordisk announces settlement of securities lawsuit in Denmark
Published: 2022-01-14 (Crawled : 17:00) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -3.67% H: 0.0% C: 0.0%

ces
Human Growth Hormone (hGH) Market to Reach $9.21 Billion, By 2030 at 9.0% CAGR: AMR
Published: 2022-01-14 (Crawled : 01:00) - prnewswire.com
VTRS | $14.64 | twitter stocktwits trandingview |
Health Technology
| | O: -1.64% H: 0.0% C: 0.0%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -3.67% H: 0.0% C: 0.0%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
ABT | News | $126.36 | twitter stocktwits trandingview |
Health Technology
| | O: -1.54% H: 0.0% C: 0.0%

growth hormone growth hormone
Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-10 (Crawled : 13:30) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 1.79% C: 1.66%


2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach
Published: 2022-01-06 (Crawled : 12:30) - biospace.com/
TSVT | $19.84 | twitter stocktwits trandingview |
| | O: 5.11% H: 6.69% C: 4.86%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -3.91% H: 3.22% C: 2.12%

ces collaboration
Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 0.93% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: 0.91% H: 0.0% C: 0.0%
BNPQF | News | $72.36 | twitter stocktwits trandingview |
Finance
| | O: 2.94% H: 0.0% C: -3.23%
SNYNF | News 3 d | $105.0 | twitter stocktwits trandingview |
Health Technology
| | O: 3.68% H: 0.0% C: 0.0%
IPHA | $4.43 | twitter stocktwits trandingview |
Health Technology
| | O: 3.0% H: 1.25% C: -0.42%
BNPQY | News | $35.98 | twitter stocktwits trandingview |
Finance and Insurance
| | O: 1.62% H: 0.17% C: -1.98%


Novo Holdings to acquire Ritedose
Published: 2022-01-04 (Crawled : 11:00) - prnewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -5.25% H: 0.0% C: 0.0%


Innate Pharma to Participate in Upcoming Investor Conferences - Jan 04, 2022
Published: 2022-01-04 (Crawled : 10:00) - biospace.com/
IPHA | $4.43 | twitter stocktwits trandingview |
Health Technology
| | O: -0.21% H: 0.0% C: -2.51%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -5.25% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: -2.03% H: 0.0% C: 0.0%

ces conference
Novo Holdings participates in EUR 110 million first closing of Sound Bioventures Fund I
Published: 2022-01-04 (Crawled : 07:00) - prnewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -5.25% H: 0.0% C: 0.0%


At 9.7% CAGR, Insulin Delivery Devices Market Size to hit USD 33.05 Billion in 2028, Says Brandessence Market Research
Published: 2022-01-03 (Crawled : 12:00) - prnewswire.com
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 0.0% C: 0.0%
PODD | $232.32 | twitter stocktwits trandingview |
Health Technology
| | O: 1.07% H: 0.0% C: 0.0%
MDT | News | $106.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: 0.0%
BDX | $263.97 | twitter stocktwits trandingview |
Health Technology
| | O: -0.43% H: 0.0% C: 0.0%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 0.0% C: 0.0%

ces ce mark device research liver insulin
Novo Nordisk A/S – Share repurchase programme
Published: 2021-12-22 (Crawled : 15:30) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 2.31% H: 1.39% C: 1.14%


Novo Holdings invests EUR 86 million in 21st.BIO, a new bioindustrial scale-up company building on technology base from Novozymes
Published: 2021-12-21 (Crawled : 07:00) - prnewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 1.2% H: 1.62% C: 1.37%

technology trial
Global $19 Billion Home-Use Insulin Delivery Devices Markets, 2015-2020 & 2021-2030
Published: 2021-12-20 (Crawled : 19:00) - prnewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 1.2% H: 1.62% C: 1.37%
MDT | News | $106.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 2.78% C: 1.68%
BDX | $263.97 | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.63% C: -0.8%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.67% C: 0.45%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 0.74% C: 0.33%
PODD | $232.32 | twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 3.22% C: 3.08%

ces device liver insulin
Novo Nordisk announces supply challenges for Wegovy® in the US
Published: 2021-12-17 (Crawled : 19:00) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -0.42% H: 0.0% C: 0.0%

wegovy ces
Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 2.6% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: 1.91% H: 0.0% C: 0.0%
SNYNF | News 3 d | $105.0 | twitter stocktwits trandingview |
Health Technology
| | O: -5.02% H: 5.6% C: 0.96%
IPHA | $4.43 | twitter stocktwits trandingview |
Health Technology
| | O: -1.27% H: 1.68% C: 0.5%
IPHYF | $4.915 | twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.0% C: 0.0%

iph6101 blood trial phase 1 cancer
Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published: 2021-12-14 (Crawled : 17:00) - prnewswire.com
TRUMF | $37.594 | twitter stocktwits trandingview |
Health Technology
| | O: -1.42% H: 0.02% C: 0.02%
MDT | News | $106.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.66% C: -0.52%
BDX | $263.97 | twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 0.1% C: -1.63%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%
AZN | News | $60.17 | twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.0% C: 0.0%
ATRS | $3.35 | twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.7% C: -0.63%
TRUMY | $36.85 | twitter stocktwits trandingview |
Manufacturing
| | O: -1.37% H: 0.68% C: 0.37%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: -1.8% H: 0.08% C: -0.43%
AZNCF | News | $121.21 | twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 5.82% C: 1.91%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.92% C: 0.66%
PODD | $232.32 | twitter stocktwits trandingview |
Health Technology
| | O: -0.82% H: 0.38% C: -2.71%
ENDP | $3.32 | twitter stocktwits trandingview |
Health Technology
| | O: -5.76% H: 7.53% C: 0.47%
SNYNF | News 3 d | $105.0 | twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -0.56%
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: 1.9% H: 0.0% C: 0.0%
BMY | $64.58 | twitter stocktwits trandingview |
Health Technology
| | O: 2.71% H: 2.77% C: 1.21%

drug liver growing drug delivery
Novo Nordisk A/S – Share repurchase programme
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 0.91% H: 0.0% C: 0.0%


Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
Published: 2021-12-09 (Crawled : 11:00) - biospace.com/
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 1.09% H: 0.32% C: -0.26%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.0% C: 0.0%
IPHA | $4.43 | twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 1.6% C: -2.8%

cancer
Needle-Free Injections Market is Growing at a CAGR of 14.15% during the Forecast Period from 2021 to 2026 and will reach USD 24.12 billion by 2026, Affirms DelveInsight
Published: 2021-12-06 (Crawled : 17:00) - prnewswire.com
TRUMF | $37.594 | twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.19% C: -2.25%
TRUMY | $36.85 | twitter stocktwits trandingview |
Manufacturing
| | O: 0.12% H: 0.2% C: 0.12%
NVO | $95.46 | twitter stocktwits trandingview |
Health Technology
| | O: 1.0% H: 0.0% C: 0.0%
WST | $373.59 | twitter stocktwits trandingview |
Health Technology
| | O: -1.59% H: 0.0% C: 0.0%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: -2.2% H: 0.0% C: 0.0%
ABBV | News | $134.37 | twitter stocktwits trandingview |
Health Technology
| | O: 1.57% H: 0.0% C: 0.0%
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: 1.49% H: 0.0% C: 0.0%

injection growing
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.64 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.16 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $73.31 | twitter stocktwits trandingview |
Finance

INCY | News | $74.76 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.73 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.6 | twitter stocktwits trandingview |
Finance